Clinical Trials Directory

Trials / Conditions / CML (Chronic Myelogenous Leukemia)

CML (Chronic Myelogenous Leukemia)

10 registered clinical trials studyying CML (Chronic Myelogenous Leukemia) — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxi
NCT06859424
Center for International Blood and Marrow Transplant ResearchPhase 2
RecruitingELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participant
NCT06787144
Enliven TherapeuticsPhase 1
WithdrawnIIT PH1 KDS-1001 in Patients With CML
NCT04808115
Duke UniversityPhase 1
CompletedRopeginterferon for Treatment Free Remission
NCT07105319
Dong-Wook KimPhase 4
UnknownA Study for PRO of CML in Real Word
NCT05092048
xuna—
CompletedPrecision Dosing of Tyrosine Kinase Inhibitors in CML Patients
NCT03885830
UNC Lineberger Comprehensive Cancer Center—
TerminatedPhase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Tra
NCT02231853
National Heart, Lung, and Blood Institute (NHLBI)Phase 1
CompletedVascular Dysfunction and Antiangiogenic Therapy
NCT02161978
University Hospital, Angers—
CompletedImproving Blood Stem Cell Collection and Transplant Procedures
NCT01517035
National Heart, Lung, and Blood Institute (NHLBI)Phase 1 / Phase 2
CompletedStem Cell Transplantation for Patients With Cancers of the Blood
NCT00467961
National Heart, Lung, and Blood Institute (NHLBI)Phase 2